{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T17:45:25Z","timestamp":1782582325314,"version":"3.54.5"},"reference-count":15,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Sage Open Medical Case Reports"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:p>Parotid gland malignancies are rare and represent less than 5% of all head and neck cancers. Squamous cell carcinoma of the parotid gland is an uncommon subtype and is often associated with aggressive clinical behavior. While regional lymphatic spread is common, distant metastases to organs such as the lungs, brain, and liver are rare but indicate advanced disease and poor prognosis. We report a 60-year-old male with primary right parotid squamous cell carcinoma who initially presented with facial nerve paralysis and locally advanced infiltrative disease requiring debulking parotidectomy followed by chemoradiotherapy. Despite multimodal treatment, the patient developed progressive metastatic disease with respiratory symptoms, ocular pain, and worsening clinical status. Computed tomography imaging revealed extensive metastatic involvement including multiple bilateral pulmonary nodules with a dominant left perihilar mass, multiple cerebral metastases demonstrating ring-enhancing lesions with marked surrounding vasogenic edema, pleural metastatic involvement, and multiple hepatic hypodense lesions. An incidental left thyroid lobe nodule was also identified and subsequent fine-needle aspiration cytology confirmed benign colloid goiter. The patient received palliative chemotherapy with carboplatin and paclitaxel alongside supportive therapy. This case highlights the aggressive metastatic potential of parotid squamous cell carcinoma, the possibility of progressive systemic dissemination despite multimodal therapy, and the importance of comprehensive imaging in detecting disease progression and guiding management.<\/jats:p>","DOI":"10.1177\/2050313x261458910","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T06:44:07Z","timestamp":1782283447000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Aggressive metastatic parotid squamous cell carcinoma with pulmonary, cerebral, and hepatic metastases: A radiologic case report"],"prefix":"10.1177","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0974-2194","authenticated-orcid":false,"given":"James Alex","family":"Sumawe","sequence":"first","affiliation":[{"name":"Department of Radiology, University of Dar es Salaam Mbeya College of Health and Allied Sciences (UDSM-MCHAS), Mbeya, Tanzania"},{"name":"Department of Radiology, Mbeya Zonal Referral Hospital, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","unstructured":"Bradley PJ. Primary malignant parotid epithelial neoplasms of the parotid gland. ORL J Otorhinolaryngol Relat Spec 2019; 81(5\u20136): 306\u2013316. https:\/\/doi.org\/10.1159\/000502389","DOI":"10.1159\/000502389"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","unstructured":"Xiao M Liu J You Y et al. Primary squamous cell carcinoma of the parotid gland: clinicopathological characteristics treatment and prognosis. Int J Oral Maxillofac Surg 2021; 50(2): 151\u2013157. https:\/\/doi.org\/10.1016\/j.ijom.2020.06.010","DOI":"10.1016\/j.ijom.2020.06.010"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","unstructured":"Fang Q Wu J Liu F. Oncologic outcome and potential prognostic factors in primary squamous cell carcinoma of the parotid gland. BMC Cancer 2019; 19(1): 752. https:\/\/doi.org\/10.1186\/s12885-019-5969-6","DOI":"10.1186\/s12885-019-5969-6"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","unstructured":"Edafe O Hughes B Tsirevelou P et al. Understanding primary parotid squamous cell carcinoma: a systematic review. Surgeon 2020; 18(1): 44\u201348. https:\/\/doi.org\/10.1016\/j.surge.2019.03.006","DOI":"10.1016\/j.surge.2019.03.006"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","unstructured":"Wang CW Chang YL Lou PJ et al. Primary squamous cell carcinoma of the parotid gland: clinical analysis of 18 patients. Head Neck 2018; 40(6): 1234\u20131240. https:\/\/doi.org\/10.1002\/hed.25089","DOI":"10.1002\/hed.25089"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","unstructured":"O\u2019Brien CJ. Current management of benign parotid tumors\u2014the role of limited superficial parotidectomy. Head Neck 2003; 25(11): 946\u2013952. https:\/\/doi.org\/10.1002\/hed.10392","DOI":"10.1002\/hed.10312"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","unstructured":"Rodriguez CP Adelstein DJ Rybicki LA et al. Patterns of distant metastases in salivary gland carcinoma. Head Neck 2021; 43(5): 1518\u20131527. https:\/\/doi.org\/10.1002\/hed.26610","DOI":"10.1002\/hed.26610"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","unstructured":"Bell D Hanna EY. Salivary gland cancers: biology and molecular targets for therapy. Nat Rev Clin Oncol 2012; 9(6): 322\u2013334. https:\/\/doi.org\/10.1038\/nrclinonc.2012.54","DOI":"10.1038\/nrclinonc.2012.54"},{"key":"e_1_3_2_10_2","unstructured":"Righi A Franchi A Morandi L et al. Imaging of salivary gland tumors. Radiol Med 2020; 125(6): 585\u2013598. https:\/\/doi.org\/10.1007\/s11547-020-01152-9"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","unstructured":"Lee YH Kim DW Shin SS et al. Multi-modality imaging of salivary gland tumors. Clin Radiol 2019; 74(6): 417\u2013428. https:\/\/doi.org\/10.1016\/j.crad.2019.01.018","DOI":"10.1016\/j.crad.2019.01.018"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","unstructured":"Locati LD Perrone F Cortelazzi B et al. Clinical activity of systemic therapy in recurrent and metastatic salivary gland carcinomas. Oral Oncol 2009; 45(9): e215\u2013e220. https:\/\/doi.org\/10.1016\/j.oraloncology.2009.03.004","DOI":"10.1016\/j.oraloncology.2008.07.010"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","unstructured":"Li M Gao J Li Z et al. Local recurrence and survival in parotid squamous cell carcinoma. J Surg Oncol 2018; 118(7): 1234\u20131242. https:\/\/doi.org\/10.1002\/jso.25235","DOI":"10.1002\/jso.25235"},{"key":"e_1_3_2_14_2","volume-title":"TNM Classification of Malignant Tumours","author":"Brierley JD","year":"2017","unstructured":"Brierley JD, Gospodarowicz MK, Wittekind C (eds). TNM Classification of Malignant Tumours. 8th ed. Wiley-Blackwell, 2017.","edition":"8"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","unstructured":"Sato R Yamaki H Komatsuda H et al. Exploring immunological effects and novel immune adjuvants in immunotherapy for salivary gland cancers. Cancers (Basel). 2024; 16(6): 1205. https:\/\/doi.org\/10.3390\/cancers16061205","DOI":"10.3390\/cancers16061205"},{"issue":"6","key":"e_1_3_2_16_2","first-page":"851","article-title":"Pembrolizumab in patients with advanced salivary gland carcinoma","volume":"22","author":"Ho AL","year":"2021","unstructured":"Ho AL, Dunn L, Sherman EJ, et al. Pembrolizumab in patients with advanced salivary gland carcinoma. Lancet Oncol 2021; 22(6): 851\u2013886.","journal-title":"Lancet Oncol"}],"container-title":["Sage Open Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2050313X261458910","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2050313X261458910","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2050313X261458910","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T16:47:48Z","timestamp":1782578868000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/2050313X261458910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":15,"alternative-id":["10.1177\/2050313X261458910"],"URL":"https:\/\/doi.org\/10.1177\/2050313x261458910","relation":{},"ISSN":["2050-313X","2050-313X"],"issn-type":[{"value":"2050-313X","type":"print"},{"value":"2050-313X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"article-number":"2050313X261458910"}}